K36 Therapeutics completes first patient cohort dosing for Phase 1 trial of KTX-2001

Cumberland Pharmaceuticals secures FDA Fast Track status for DMD heart‑disease therapy ifetroban

Cizzle Biotechnology secures Canadian patent for lung cancer biomarker test

Biosion reports first patient dosed in Phase 1a/1b trial of BSI-082

AbbVie submits FDA and EMA applications for new upadacitinib indication in NSV

Relay Therapeutics wins FDA breakthrough status for zovegalisib in breast cancer treatment

DATROWAY receives US priority review for first-line metastatic triple negative breast cancer

Valneva and Instituto Butantan launch pilot chikungunya vaccination campaign in Brazil

Lupin launches Dasatinib tablets in US market

WuXi Biologics enters into licence and research service agreement with Vertex Pharmaceuticals

Natera submits Signatera CDx PMA to FDA for bladder cancer use

Pharming receives FDA complete response letter for paediatric Joenja application

Astrazeneca Imfinzi perioperative regimen gains positive EU CHMP opinion in early gastric cancer

I Peace generates human iPS cells from NKT cells and offers them for research use

Trace Biosciences' IND application for nerve-specific imaging agent approved by FDA